摘要 | Interstitial Lung Disease Improvement In Patients With Rheumatoid Arthritis And Tofacitinib

研究论著 | Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.

研究论著 | Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.

研究论著 | Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.

研究论著 | Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice.

综述 | Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis.

摘要 | AB0418 Interstitial Lung Disease in Patients with Rheumatoid Arthritis Treated with Tofacitinib

研究论著 | Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis.

综述 | The lung in rheumatoid arthritis, cause or consequence?

综述 | Lung disease in rheumatoid arthritis.

研究论著 | Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial.

研究论著 | Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases